Weight Management

Petrelintide

ZP8396 · Zealand petrelintide

Zealand Pharma investigational long-acting amylin receptor agonist (petrelintide / ZP8396). Not pramlintide. Not cagrilintide. Not a research vial that inherits Symlin labeling.

Not FDA-approved - research chemical

Reviewed by CalcMyPeptide Editorial Team

·Last updated: September 2026·Evidence: Emerging

Typical research dose

Investigational - sponsor protocol only

Frequency

Trial schedules only

Half-life

Long-acting program (sponsor PK)

Common vials

N/A (oral)

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

Metabolic / weight5.5/10
Amylin-pathway obesity programs are real. Haircut: investigational, not pramlintide label, not a DIY cake.

Compound card

Sequence: Long-acting amylin agonist (ZP8396 / petrelintide)
Class: Investigational long-acting amylin receptor agonist (Zealand Pharma)
Formula: Amylin analog (proprietary)
Status: Not FDA-approved · research use

How it works

Petrelintide (ZP8396) is Zealand Pharma’s investigational long-acting amylin receptor agonist. It sits in the amylin satiety class with pramlintide and cagrilintide, but it is not Symlin and not cagrilintide.

Source: Zealand Pharma clinical program disclosures; not a finished US label

Research Use Cases

✓Amylin pipeline literacy: Moderate
✓DIY reconstitution: Low

Dosing

Phase	Dose	Frequency	Notes
Human care	Sponsor protocol only	Trial schedule	Not Symlin pen math.
Research-chem SKU	Do not invent	n/a	Identity first.

Administration

Route / form

Parenteral under clinical protocol

Timing

Program-defined

Empty stomach?

No - Food timing is not critical.

Timeline

Trial programs

Satiety endpoints are sponsor-owned.

Who it is for

Amylin pipeline literacy

Moderate

Keep it distinct from GLP-1-only drugs.

DIY reconstitution

Low

Wrong tool.

Safety & Considerations

Investigational. Amylin-class nausea risk. Hypoglycemia risk rises when stacked carelessly with insulin — that is clinical pharmacology, not a gray-vial excuse. Unverified identity risk on research SKUs.

Regulatory & Legal Status

FDA Status (US)

Research Only

WADA Status (2026)

Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.